Stay updated on CMG901 Safety, Tolerability, PK, and Preliminary Efficacy Clinical Trial
Sign up to get notified when there's something new on the CMG901 Safety, Tolerability, PK, and Preliminary Efficacy Clinical Trial page.

Latest updates to the CMG901 Safety, Tolerability, PK, and Preliminary Efficacy Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.3%
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.SummaryDifference1.0%
- Check30 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for February 12, 2025, while a date for March 25, 2025, has been removed.SummaryDifference1.0%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check80 days agoChange DetectedThe page has been updated to reflect a new completion status and a specific date of February 12, 2025, while previous statuses and dates have been removed.SummaryDifference2%
- Check87 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference6%
Stay in the know with updates to CMG901 Safety, Tolerability, PK, and Preliminary Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CMG901 Safety, Tolerability, PK, and Preliminary Efficacy Clinical Trial page.